Home
About
Overview
Sharing Data
ORCID
Help
History (64)
Comparison of region-of-interest-averaged and pixel-averaged analysis of DCE-MRI data based on simulations and pre-clinical experiments.
Gastrointestinal Tract
Aftercare
Blood Coagulation Disorders
A Phase II trial of fixed dose rate gemcitabine in patients with advanced biliary tree carcinoma.
See All 64 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A Phase II trial of fixed dose rate gemcitabine in patients with advanced biliary tree carcinoma.
A Phase II trial of fixed dose rate gemcitabine in patients with advanced biliary tree carcinoma. Am J Clin Oncol. 2004 Dec; 27(6):565-9.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Antimetabolites, Antineoplastic
Bile Duct Neoplasms
Cholangiocarcinoma
Deoxycytidine
Female
Gallbladder Neoplasms
Humans
Male
Middle Aged
Survival Analysis
authors with profiles
Hedy Kindler